If you enjoy this content, please share it with a colleague
RELATED CONTENT
Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...
Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
August 18, 2025 – Akumin, a national leader in outpatient radiology and oncology services, has selected Lunit INSIGHT ...
July 2, 2025 — Lunit, a provider of AI for cancer diagnostics and therapeutics, has announced a collaboration with ...
March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...
Jan. 23, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a new ...
Dec. 12, 2024 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, recently announced ...
Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...
Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...
December 02, 2025 